Related Experiment Video
Updated: May 26, 2026

Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
Differential role of BCL2 in molecular subtypes of diffuse large B-cell lymphoma
Kieron Dunleavy1, Wyndham H Wilson
1National Cancer Institute, Bethesda, MD 20892, USA. dunleavk@mail.nih.gov
Abstract:
Gene expression profiling has been used to divide diffuse large B-cell lymphoma into distinct molecular subtypes with different outcomes following immunochemotherapy. Recently, researchers have shown much interest in investigating the role of biomarkers, such as BCL2, in predicting outcome in diffuse large B-cell lymphoma, particularly in the context of these molecular subtypes.
Related Concept Videos
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
The Intrinsic Apoptotic Pathway
Differentiation of Common Myeloid Progenitor Cells

